West Pharmaceutical Services, Inc.

NYSE:WST Stock Report

Mkt Cap: US$20.0b

West Pharmaceutical Services Financial Health

How is West Pharmaceutical Services's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: WST's short term assets ($1.7B) exceed its short term liabilities ($456.7M).

Long Term Liabilities: WST's short term assets ($1.7B) exceed its long term liabilities ($389.3M).


Debt to Equity History and Analysis

Debt Level: WST has more cash than its total debt.

Reducing Debt: WST's debt to equity ratio has reduced from 17.5% to 8.5% over the past 5 years.

Debt Coverage: WST's debt is well covered by operating cash flow (312.3%).

Interest Coverage: WST's interest payments on its debt are well covered by EBIT (117.8x coverage).


Balance Sheet


Discover healthy companies